France· FR:67316379
IBRANCE 75 mg, gélule
A medicinal product containing palbociclib, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PALBOCICLIB
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300752723 plaquette(s) PVC polychlortrifluoroéthylène aluminium de 7 gélule(s)EUR 1.63
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Palbociclib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIBRANCEPfizer Europe MA EEIG, Bruxelles
- United StatesIbrancePfizer Laboratories Div Pfizer Inc
- United KingdomIbrance 75mg capsulesOriginalis B.V.
- SpainIBRANCE 75 MG CAPSULAS DURASPfizer Europe Ma Eeig
- IcelandIbrancePfizer Europe MA EEIG*
- NetherlandsIbrance 75 mg, harde capsulePfizer Europe MA EEIG
- PolandIbrancePfizer Europe MA EEIG
- SwedenIBRANCE 75 mg Kapsel, hårdPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Ibrammaclib
- Bulgaria · Palbociclib
- Denmark · Palbociclib Newbury
- Estonia · Palbociclib
- Finland · Palbociclib Avansor
- United Kingdom (Northern Ireland) · Palbociclib Thornton & Ross
- Greece · Palbociclib Faran
- Croatia · Palbociclib
- Hungary · Palbociclib
- Iceland · Ibrance, Palbociclib Viatris
- Liechtenstein · Ibrance, Palbociclib Viatris
- Malta · Palbociclib, Palbociclib Lotus
- Netherlands · Ibaclib, Palbociclib Elpen
- Norway · Ibrance, Palbociclib Newbury
- Poland · Palbociclib Polpharma
- Sweden · Brancen, Brical
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/175a689a-4465-4d00-937e-54fc9dcb3c9a GET /v1/drugs/175a689a-4465-4d00-937e-54fc9dcb3c9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67316379",
"date_amm": "2016-11-09",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1147",
"substance": "PALBOCICLIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about palbociclib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.